1
|
Reyes-Valdivia A, Kratimenos T, Ferraresi M, Sica S, Lovato L, Accarino G, Pagliaricco G, Tshomba Y, Tinelli G. A multicenter "real-world" study of the valiant NAVION stent graft. Int J Cardiol 2020; 331:63-68. [PMID: 33164839 DOI: 10.1016/j.ijcard.2020.10.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/09/2020] [Revised: 09/23/2020] [Accepted: 10/20/2020] [Indexed: 11/17/2022]
Abstract
BACKGROUND The aim of the present study was to evaluate early results of thoracic endovascular aortic repair (TEVAR) using the Valiant Navion™ stent graft in a "real-world" scenario. METHODS All patients who underwent TEVAR with the Valiant Navion™ endograft between November 2018 and November 2019 were included in this retrospective multicenter study (six European centers). The primary endpoints were technical success, incidence of major adverse events (MAEs), access failure, deployment failure, deployment accuracy, and rate of intraoperative endoleaks (ELs). RESULTS One hundred-sixteen patients with varying thoracic aortic diseases were included. Eighteen patients (15.5%) were treated for an off-label condition. The technical success rate was 100%, without any access or deployment failures. The proximal and distal deployment accuracy rates were 99.1% and 97.4%, respectively. There were no intraoperative MAEs, including death. Two (1.7%) type Ib ELs were detected at the first postoperative CTA, all of which were in off-label procedures and related to the short length of the sealing neck. No type III ELs were detected. The median hospitalization time was 8 days (IQR 4-12), including a median intensive care unit stay of 1 day (IQR 1-2). The in-hospital mortality rate was 4.3%. At a median follow-up time of 98 days (IQR 39-187), there were no aortic-related mortalities or new onset of endoleaks. CONCLUSION Our initial experience with the Valiant Navion™ endograft in a wide variety of aortic diseases showed safe early outcomes, especially for on-label procedures.
Collapse
Affiliation(s)
- Andrés Reyes-Valdivia
- Department of Vascular and Endovascular Surgery, Ramón y Cajal's University Hospital, 28034 Madrid, Spain
| | - Theodoros Kratimenos
- Interventional Radiology Department, Evangelismos Hospital, 10676 Athens, Greece
| | - Marco Ferraresi
- School of Vascular Surgery, University of Milan, 20122 Milan, Italy
| | - Simona Sica
- Unit of Vascular Surgery, Fondazione Policlinico Universitario Gemelli IRCCS - Università Cattolica del Sacro Cuore, 00168 Rome, Italy
| | - Luigi Lovato
- Cardiovascular Radiology Unit, Cardiovascular and Thoracic Department S. Orsola, Malpighi Hospital, 40138 Bologna, Italy
| | - Giancarlo Accarino
- U.O.C. di Chirurgia Vascolare ed Endovascolare, Azienda Ospedaliera Universitaria San Giovanni di Dio e Ruggi d'Aragona, 84131 Salerno, Italy
| | - Gabriele Pagliaricco
- Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona, 60020 Ancona, Italy
| | - Yamume Tshomba
- Unit of Vascular Surgery, Fondazione Policlinico Universitario Gemelli IRCCS - Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
| | - Giovanni Tinelli
- Unit of Vascular Surgery, Fondazione Policlinico Universitario Gemelli IRCCS - Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
| |
Collapse
|
2
|
Coster BD, Houthoofd S, Laenen A, Fourneau I, Maleux G. Overall survival and factors predicting long-term outcome after thoracic aortic endovascular repair. Scand J Surg 2020; 110:386-394. [PMID: 32126933 DOI: 10.1177/1457496920910004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
PURPOSES To assess overall survival and to determine factors predicting outcome after thoracic endovascular aortic repair. MATERIALS AND METHODS A Retrospective analysis was performed on a cohort of 212 consecutive patients (165 men and 47 women; mean age 64 years) who underwent thoracic endovascular aortic repair in a tertiary referral center for aortic disease. Main indications were true thoracic aortic aneurysm (n = 58; 27.6%), traumatic aortic rupture (n = 33; 15.7%), anastomotic pseudoaneurysms (n = 23; 10.9%), chronic type B aortic dissection (n = 22; 10.5%), and symptomatic, acute type B dissection (n = 21; 10.0%). In 79 patients (37.3%), a hybrid procedure, including supra-aortic rerouting, was performed. Kaplan-Meier estimates were used for overall survival and Cox regression models were used for univariable analysis of the association between risk factors and survival. RESULTS Proximal landing zones were predominantly zone 3 (n = 66; 31.3%), zone 2 (n = 63; 29.9%), and zone 1 (n = 38; 18%). In-hospital mortality was n = 18 (8.5%). Overall survival was 79.6%, 65.9%, and 51.1% at 2, 5, and 10 years, respectively; better overall survival was shown for traumatic aortic rupture, anastomotic pseudoaneurysms, and chronic posttraumatic pseudoaneurysms (p < 0.05). Clinical risk factors influencing overall survival include prior coronary bypass surgery, atrial flutter, arterial hypertension, renal failure, chronic obstructive pulmonary disease, and associated abdominal aortic aneurysm (p < 0.05). CONCLUSIONS Thoracic endovascular aortic repair is an effective treatment option for various thoracic aortic diseases with highest survival rates for traumatic aortic rupture and anastomotic pseudoaneurysms. Several clinical parameters are identified as risk factors for overall survival.
Collapse
Affiliation(s)
- Bruno De Coster
- Department of Radiology, University Hospitals Leuven, Leuven, Belgium
| | - Sabrina Houthoofd
- Department of Vascular Surgery, University Hospitals Leuven, Leuven, Belgium
| | - Annouschka Laenen
- Interuniversity Institute for Biostatistics and Statistical Bioinformatics, KU Leuven and Universiteit Hasselt, Leuven, Belgium
| | - Inge Fourneau
- Department of Vascular Surgery, University Hospitals Leuven, Leuven, Belgium
| | - Geert Maleux
- Department of Radiology, University Hospitals Leuven, Herestraat 49, Leuven, B-3000, Belgium
| |
Collapse
|
3
|
Väärämäki S, Suominen V, Pimenoff G, Saarinen J, Uurto I, Salenius J. Long-Term Experience of Endovascular Repair for Thoracic Aortic Aneurysms and Dissections. Vasc Endovascular Surg 2016; 50:335-42. [DOI: 10.1177/1538574416652244] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Purpose: To report the long-term results of thoracic endovascular aortic repair (TEVAR) in both elective and emergency cases of thoracic aortic aneurysm (TAA) and type B dissection. Material and Methods: A prospective single-center study of 78 TEVAR patients treated between February 1998 and February 2013. Stent-graft implantation was performed in 51 (65%) patients for TAA (43 elective and 8 emergency cases) and in 27 (35%) patients for type B dissection (11 elective and 16 emergency cases). Short- and long-term results were evaluated, and a subgroup of patients with left subclavian artery (LSA) coverage was also analyzed. Results: The patients were followed for a mean of 55 months (1-160 months). The technical success rate was 81% and 30-day mortality 6.4% (n = 5). The stroke rate was 7.7% (n = 6) and permanent paraparesis 2.6% ( n = 2). In follow-up, there were 28 (36%) primary (15 type I and 13 type II) and 10 secondary endoleaks (8 type I and 2 type II). Multivariate analysis showed no significant predictive factors for developing a type I endoleak. Secondary interventions were required in 24% of the patients. There was 1 late thoracic aortic rupture and 1 late conversion (1.3%). Patients with LSA coverage had a higher incidence of stroke (12.5% vs 4.3%, P = .18) and paraparesis (3.1% vs 2.2%, P = .79) compared to those without LSA coverage, although this difference was not statistically significant. Stroke rates were significantly higher in patients treated in an emergency setting ( P = .048). Conclusion: Thoracic endovascular aortic repair is a relatively safe and effective therapy for different aortic pathologies with good long-term success. The risk of stroke and paraparesis is notable whether the LSA is covered, and strokes clearly accumulate in the emergency setting. A type I endoleak is the most common complication, but there are no predictive factors for its development.
Collapse
Affiliation(s)
- Suvi Väärämäki
- Department of Surgery, Division of Vascular Surgery, Tampere University Hospital, Tampere, Finland
- School of Medicine, University of Tampere, Tampere, Finland
- Seinäjoki Central Hospital, Seinäjoki, Finland
| | - Velipekka Suominen
- Department of Surgery, Division of Vascular Surgery, Tampere University Hospital, Tampere, Finland
- School of Medicine, University of Tampere, Tampere, Finland
| | - Georg Pimenoff
- Department of Radiology, Division of Interventional Radiology, Tampere University Hospital, Tampere, Finland
| | - Jukka Saarinen
- Department of Surgery, Division of Vascular Surgery, Tampere University Hospital, Tampere, Finland
- School of Medicine, University of Tampere, Tampere, Finland
| | - Ilkka Uurto
- Department of Surgery, Division of Vascular Surgery, Tampere University Hospital, Tampere, Finland
| | - Juha Salenius
- Department of Surgery, Division of Vascular Surgery, Tampere University Hospital, Tampere, Finland
- School of Medicine, University of Tampere, Tampere, Finland
| |
Collapse
|
4
|
Biancari F, Mariscalco G, Mariani S, Saari P, Satta J, Juvonen T. Endovascular Treatment of Degenerative Aneurysms Involving Only the Descending Thoracic Aorta. J Endovasc Ther 2016; 23:387-392. [DOI: 10.1177/1526602815626560] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2023]
Abstract
Purpose: To determine the efficacy of thoracic endovascular aortic repair (TEVAR) for degenerative aneurysm involving only the descending thoracic aorta (DTAA). Methods: An English-language literature review was performed through PubMed, Scopus, and Google Scholar to identify any study evaluating the outcomes of TEVAR for DTAA. The main endpoints of this analysis were all-cause 30-day and late postoperative mortality. Secondary outcome measures were procedure success, vascular access complications, paraplegia, stroke, early endoleaks during the index hospitalization, aneurysm-related death, reinterventions, and conversion to open repair. To control for the anticipated heterogeneity among small observational studies, absolute values and means were pooled using random effects models; the results are expressed as pooled proportions, means, or risk ratio (RR) with 95% confidence intervals (CIs). Results: Eleven studies reporting on 673 patients (mean age 72.6 years, mean aneurysm diameter 62.9 cm) with DTAA were selected for the analysis. Technical success was reported in 91.0% of patients, and vascular access complications requiring repair were encountered in 9.7% of cases. Pooled overall 30-day, 1-year, 2-year, and 3-year survival rates were 96.0%, 80.3%, 77.3%, and 74.0%, respectively. Five studies compared the results of TEVAR after elective (n=151) and urgent/emergent procedure (n=77); the latter was a predictor of 30-day mortality (17.1% vs 1.8%, RR 3.83, 95% CI 1.18 to 12.40, p=0.025). Paraplegia occurred in 3.2% of patients and was permanent in 1.4% of patients. The stroke rate was 2.7%. Early type I endoleak was observed in 7.3%, type II endoleak in 2.0%, and type III in 1.2% of patients. The mean follow-up of 9 studies was 22.3 months. At 3 years, freedom from reintervention was 90.3%. Death secondary to aneurysm rupture and/or fistula was reported in 3.2% of patients. Conclusion: Current results indicate that TEVAR for DTAA can be performed with rather high technical success, low postoperative morbidity, and good 3-year survival.
Collapse
Affiliation(s)
- Fausto Biancari
- Department of Surgery, Oulu University Hospital, Oulu, Finland
| | - Giovanni Mariscalco
- Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, UK
| | - Silvia Mariani
- Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, UK
| | - Petri Saari
- Department of Clinical Radiology, Kuopio University Hospital, Kuopio, Finland
| | - Jari Satta
- Department of Surgery, Oulu University Hospital, Oulu, Finland
| | - Tatu Juvonen
- Department of Surgery, University of Oulu, Finland
- Department of Cardiac Surgery, HUCH Heart and Lung Center, Helsinki University Central Hospital, Helsinki, Finland
| |
Collapse
|
5
|
Sobocinski J, Patterson BO, Karthikesalingam A, Thompson MM. The Effect of Left Subclavian Artery Coverage in Thoracic Endovascular Aortic Repair. Ann Thorac Surg 2016; 101:810-7. [DOI: 10.1016/j.athoracsur.2015.08.069] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/12/2015] [Revised: 07/08/2015] [Accepted: 08/26/2015] [Indexed: 10/22/2022]
|
6
|
Hughes K, Guerrier J, Obirieze A, Ngwang D, Rose D, Tran D, Cornwell E, Obisesan T, Preventza O. Open Versus Endovascular Repair of Thoracic Aortic Aneurysms. Vasc Endovascular Surg 2014; 48:383-7. [DOI: 10.1177/1538574414540484] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Purpose: Endovascular repair of descending thoracic aortic aneurysms has become an acceptable surgical option over the past decade. We sought to compare the results of open versus endovascular repair of thoracic aortic aneurysms (TEVAR) in the United States. Methods: The Nationwide Inpatient Sample (NIS) database was queried to identify all patients undergoing elective repair of a thoracic aortic aneurysm from 1998 to 2007 in the United States. Patient demographic data, preoperative comorbidities, and postoperative complications were recorded. Statistical analyses were performed comparing open versus endovascular repair. Multivariate analyses were conducted controlling for preoperative comorbidities including the presence of diabetes mellitus, cardiac, respiratory, and renal comorbidities as well as patient’s age, gender, and ethnicity. The primary end point was mortality. Secondary end points were postoperative neurologic, cardiac, and respiratory complications. Results: There were 8967 patients who met the inclusion criteria. Of these patients, 8255 (92%) had an open repair and 712 (8%) had an endovascular repair. The overall mortality was 4.5% (4.6% for open and 3.6% for endovascular). On multivariate analysis, the odds of death were reduced by 46% among patients undergoing endovascular repair when compared to open repair (odds ratio [OR]: 0.54; P = .016). There was also reduced odds of a postoperative neurologic complication (OR: 0.48; P = .015), cardiac complication (OR: 0.24; P < .001), and respiratory complication (OR: 0.38: P = .001) in the endovascular group. Conclusions: Nationwide data comparing open and TEVAR in the United States reveal decreased postoperative mortality and a decreased incidence of postoperative neurologic, cardiac, and respiratory complications for TEVAR.
Collapse
Affiliation(s)
- Kakra Hughes
- Department of Surgery, Howard University College of Medicine, Washington, DC, USA
| | - Jean Guerrier
- Department of Surgery, University of Virginia, Charlottesville, VA, USA
| | - Augustine Obirieze
- Department of Surgery, Howard University College of Medicine, Washington, DC, USA
| | - Dora Ngwang
- Department of Anesthesiology, Case Western Reserve University School of Medicine, Cleveland, OH, USA
| | - David Rose
- Department of Surgery, Howard University College of Medicine, Washington, DC, USA
| | - Daniel Tran
- Department of Surgery, Howard University College of Medicine, Washington, DC, USA
| | - Edward Cornwell
- Department of Surgery, Howard University College of Medicine, Washington, DC, USA
| | - Thomas Obisesan
- Department of Medicine, Howard University College of Medicine, Washington, DC, USA
| | - Ourania Preventza
- Division of Cardiothoracic Surgery, Baylor College of Medicine, Texas Heart Institute, Houston, TX, USA
| |
Collapse
|
7
|
Preventza O, Hughes K. Endovascular repair of the descending thoracic aorta: a tale of two nations. J Endovasc Ther 2013; 20:273-5. [PMID: 23731295 DOI: 10.1583/12-4203c.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- Ourania Preventza
- Department of Cardiovascular Surgery, Texas Heart Institute at St. Luke's Episcopal Hospital, and the Michael E. DeBakey Division of Cardiothoracic Surgery, Baylor College of Medicine, Houston, Texas, USA
| | | |
Collapse
|